Skip to main content

Table 2 Significantly different chromosomal alterations between hrHPV+ and hrHPV- carcinomas.

From: Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck

     

HPV+ (HNSCC; CxSCC)

HPV-

chromosome

Start (Mb)

End (Mb)

Cytoband

FDR

% loss

% gain

% amp

% loss

%gain

%amp

1

1.08

58.69

1p36.33-p32.2

0.08

0.0

26.7 (15.6; 40.0)

0.0

14.6

5.8

0.0

1

109.78

117.23

1p13.3-p13.1

0.04

0.0

13.6 (16.7; 10.0)

0.0

17.8

0.0

0.0

2

96.17

97.68

2q11.2

0.08

4.5 (0.0; 10.1)

0.0

0.0

0.0

20.0

0.0

2

165.89

180.53

2q24.3-q31.3

0.06

9.1 (8.3; 10.0)

0.0

0.0

0.0

18.9

0.0

3

0.28

86.18

3p26.3-p12.1

0.00

17.8 (20.5; 14.6)

9.4 (3.8; 16.2)

0.0

86.2

0.5

0.0

5

51.16

180.57

5q11.2-q35.3

0.00

8.6 (7.5; 10.0)

9.1 (8.3; 10.0)

0.0

61.0

0.3

0.0

7

9.95

25.67

7p21.3-p15.2

0.05

13.6 (16.7; 10.0)

0.0

0.0

3.3

21.7

0.0

7

65.52

116.45

7q11.21-q31.2

0.03

4.5 (0.0; 10.0)

0.3 (0.6; 0.0)

0.0

4.1

32.1

2.8

8

0.38

34.51

8p23.3-p12

0.02

6.8 (12.5; 0.0)

17.3 (31.7; 0.0)

0.0

48.7

12.0

0.0

8

75.65

93.93

8q21.11-q22.1

0.06

0.0

22.7 (41.7; 0.0)

0.0

3.3

57.8

0.0

8

114.72

145.68

8q23.3-q24.3

0.05

0.3 (0.0; 0.7)

34.4 (55.4; 9.3)

0.0

0.5

70.2

2.1

11

69.18

70.31

11q13.3-q13.4

0.04

11.4 (12.5; 10.0)

13.6 (0.0; 30.0)

4.5 (8.3; 0.0)

10.0

15.0

41.7

13

55.72

71.49

13q21.1-q21.33

0.06

66.7 (64.8; 68.9)

0.0

0.0

33.0

7.0

2.2

14

47.08

61.97

14q21.3-q23.2

0.08

11.4 (12.5; 10.0)

2.3 (0.0; 5.0)

0.0

8.3

28.3

0.0

14

79.43

86.91

14q31.1-q31.3

0.09

18.2 (25.0; 10.0)

9.1 (0.0; 20.0)

0.0

6.7

33.3

0.0

18

28.34

75.62

18q12.1-q23

0.03

10.0 (8.3; 12.0)

18.2 (25.0; 10.0)

0.0

42.7

2.0

0.0

20

15.56

60.28

20p12.1-q13.33

0.06

1.5 (2.8; 0.0)

58.5 (41.7; 78.7)

0.0

6.2

24.0

0.0

21

14.68

46.85

21q11.2-q22.3

0.00

1.1 (0.0; 2.5)

25.0 (14.6; 37.5)

0.0

33.3

2.5

0.0

  1. hrHPV-specific alterations are printed in bold. Alterations specific for hrHPV-negative HNSCCs are italicised. Mb; Megabases, FDR; False Discovery Rate, amp; amplification